
Atea Pharmaceuticals Investor Relations Material
Latest events

Status Update
Atea Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Atea Pharmaceuticals Inc
Access all reports
Atea Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing antiviral therapies for the treatment of viral diseases. The company's research and development efforts primarily target diseases such as hepatitis C, dengue, and COVID-19. Atea leverages its expertise in nucleoside and nucleotide therapeutics to create treatments aimed at addressing unmet medical needs in the antiviral space. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Atea Pharmaceuticals Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
Atea Pharmaceuticals Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
Atea Pharmaceuticals Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
AVIR
Country
🇺🇸 United States